People: Biohaven Pharmaceutical Holding Company Ltd (BHVN.N)
Mr. Robert Berman M.D., serves as Chief Medical Officer of Biohaven Pharmaceutical Holding Company Limited. Dr. Berman has served as our chief medical officer since November 2015. From December 2013 to November 2015, he served as president of Biohaven Medical Services LLC and, prior to that, served as a group director of global clinical research at BMS from September 2003 to November 2013. Prior to his time at BMS, Dr. Berman was an associate director of clinical sciences, early development at Pfizer from November 2000 to September 2003. Since October 2012, Dr. Berman has also continued to serve as an adjunct professor of psychiatry at Yale University School of Medicine. Dr. Berman received his B.A. in molecular biophysics and biochemistry from Yale University and his M.D. from Mount Sinai School of Medicine of New York University.
|Total Annual Compensation, USD||515,729|
|Restricted Stock Award, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||5,331|
|Fiscal Year Total, USD||521,060|